Comgest Global Investors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Analog Devices
ADI
|
+$31.2M |
| 2 |
TSMC
TSM
|
+$16M |
| 3 |
Fomento Económico Mexicano
FMX
|
+$13M |
| 4 |
Johnson & Johnson
JNJ
|
+$5.75M |
| 5 |
Globant
GLOB
|
+$4.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$66.7M |
| 2 |
Accenture
ACN
|
+$36.4M |
| 3 |
Ecolab
ECL
|
+$30.8M |
| 4 |
Cognizant
CTSH
|
+$26.5M |
| 5 |
Verisk Analytics
VRSK
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.46% |
| 2 | Healthcare | 24.35% |
| 3 | Consumer Staples | 9.74% |
| 4 | Consumer Discretionary | 9.02% |
| 5 | Communication Services | 8.22% |
Similar funds
Comgest Global Investors's Q3 2022 Portfolio in Review
As of Q3 2022, Comgest Global Investors held 62 positions worth $4.55B, down 11% from $5.09B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Comgest Global Investors withdrew a net $189M in Q3 2022, closing 1 position and reducing 29 holdings. Its most notable exit was Comcast, an estimated $1.51M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 35% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Comgest Global Investors opened a new position in Thermo Fisher Scientific worth $2.2M.
- Comgest Global Investors's largest Q3 2022 buy was Thermo Fisher Scientific: 4,344 shares worth $2.2M.
- Comgest Global Investors added most to Analog Devices in Q3 2022, an estimated $31.2M increase.
- Comgest Global Investors's biggest Q3 2022 reduction was Intuit, cutting an estimated $66.7M.
- Comgest Global Investors fully exited Comcast in Q3 2022, selling an estimated $1.51M.
- Comgest Global Investors's ten largest holdings make up 61% of its $4.55B portfolio in Q3 2022.
- Comgest Global Investors opened 1 new position and closed 1 in Q3 2022.
- Comgest Global Investors's portfolio value fell 11% quarter-over-quarter to $4.55B.
Based on Comgest Global Investors's 13F filing for Q3 2022, filed 10 Nov 2022.